Collaborations Pharmaceuticals


Collaborations Pharmaceuticals, Inc.® (CPI) is a privately owned company that performs research and development on innovative therapeutics with a preclinical pipeline of treatments for rare and neglected diseases. We partner with academics and companies to identify and translate early preclinical stage assets. Our goal is to bring multiple therapeutics to the clinic using our machine learning technologies (Assay Central) as well as curated model bundles (MegaTox®, MegaTrans® and MegaPredict®). We have also developed generative models for molecule design (MegaSyn). Learn more about our preclinical and computational approaches to drug discovery and toxicity prediction please see

Get Involved At World Orphan Drug Congress USA


To Sponsor Or Exhibit


Justin Franks
t/ +1 914 819 3506




To Speak


Claire Murphy
t/ +1 646 619 1784




Marketing & Press Opportunities


Taylor Post
t/ +1 646 619 1785